Richard Puleston

Contact

• workRoom A40F Clinical Sciences Building
  Nottingham City Hospital
  Hucknall Road
  Nottingham
  NG5 1PB
  UK
• work0115 823 1812
• richard.puleston@nottingham.ac.uk

Biography

Dr Richard Puleston achieved his degree in medicine from the University of Birmingham in 1992, before going on to train in General Practice in Birmingham and in Public Health in the East Midlands. He has also achieved a Master's degree in Management from the Open University.

Dr Puleston is jointly appointed with the University of Nottingham and the Health Protection Agency East Midlands.

Expertise Summary

Keywords:

Influenza, healthcare associated infection, blood borne viruses, Clostridium difficile, zoonotic diseases (jointly appointed with vet school), healthcare management

Teaching Summary

Dr Puleston convenes APH2 Public Health module for the second year medical students as well as teaching on a number of modules, including the first year module Public Health 1, and the Master's… read more

Research Summary

Dr Puleston works in a wide range of different areas across epidemiology, public health and health protection, including the recent multi-centre study of transplacental transmission of influenza… read more

Recent Publications

• BECK CR, CLOKE R, O'MOORE E and PULESTON R, 2012. Hepatitis B Vaccination Coverage And Uptake In Prisons Across England And Wales 2003-2010: A Retrospective Ecological Study. Vaccine. 30(11), 1965-71
• PULESTON, R, 2011. Use of Antivirals in an Influenza Pandemic Department of Health. 1-317
• BECK CR, MCKENZIE BC, HASHIM AB, HARRIS RC, ZANUZDANA A, AGBOADO G, ORTON E, BÉCHARD-EVANS L, MORGAN G, STEVENSON C, WESTON R, MUKAIGAWARA M, ENSTONE J, AUGUSTINE G, BUTT M, KIM S, PULESTON R, DABKE G, HOWARD R, O'BOYLE J, O'BRIEN M, AHYOW L, DENNESS H, FARMER S, FIGUREROA J, FISHER P, GREAVES F, HAROON M, HAROON S, HIRD C, ISBA R, ISHOLA DA, KERAC M, PARISH V, ROBERTS J, ROSSER J, THEAKER S, WALLACE D, WIGGLESWORTH N, LINGARD L, VINOGRADOVA Y, HORIUCHI H, PEÑALVER J and NGUYEN-VAN-TAM JS, 2011. Influenza Vaccination For Immunocompromised Patients: Systematic Review And Meta-Analysis From A Public Health Policy Perspective. Plos One. 6(12), e29249
• PULESTON, R, MYLES, P, SIEBERT, P and CHILDS, K, 2011. Where is public health leadership in England? Lancet. 378 (9805), 1776-1777

• View all publications

Dr Puleston convenes APH2 Public Health module for the second year medical students as well as teaching on a number of modules, including the first year module Public Health 1, and the Master's module in Public Health. He also teaches on the implications of zoonotic disease to Veterinary Medicine and Science students, and teaches and supports public health trainees in the East Midlands, particularly in relation to exams. As well as this, he currently supervises several PhD students.

Current Research

Dr Puleston works in a wide range of different areas across epidemiology, public health and health protection, including the recent multi-centre study of transplacental transmission of influenza antibodies following vaccination with adjuvanted (H1N1) 2009 vaccine (mummy flu) study. This study investigated whether mothers who were vaccinated against H1N1 v. (pandemic specific) influenza transferred that immunity to their children, to risk factors for an infant mortality study in premature babies.

Other current projects and areas of research include:

• Clostridium difficle- investigating risk factors for acquisition using a general practice database, as well as researching these bacteria in relation to acquisition from meat.
• Evaluating the East Midlands Platform on Obesity and Inactivity.
• Hepatitis B coverage in prisons.

• BECK CR, CLOKE R, O'MOORE E and PULESTON R, 2012. Hepatitis B Vaccination Coverage And Uptake In Prisons Across England And Wales 2003-2010: A Retrospective Ecological Study. Vaccine. 30(11), 1965-71
• PULESTON, R, 2011. Use of Antivirals in an Influenza Pandemic Department of Health. 1-317
• BECK CR, MCKENZIE BC, HASHIM AB, HARRIS RC, ZANUZDANA A, AGBOADO G, ORTON E, BÉCHARD-EVANS L, MORGAN G, STEVENSON C, WESTON R, MUKAIGAWARA M, ENSTONE J, AUGUSTINE G, BUTT M, KIM S, PULESTON R, DABKE G, HOWARD R, O'BOYLE J, O'BRIEN M, AHYOW L, DENNESS H, FARMER S, FIGUREROA J, FISHER P, GREAVES F, HAROON M, HAROON S, HIRD C, ISBA R, ISHOLA DA, KERAC M, PARISH V, ROBERTS J, ROSSER J, THEAKER S, WALLACE D, WIGGLESWORTH N, LINGARD L, VINOGRADOVA Y, HORIUCHI H, PEÑALVER J and NGUYEN-VAN-TAM JS, 2011. Influenza Vaccination For Immunocompromised Patients: Systematic Review And Meta-Analysis From A Public Health Policy Perspective. Plos One. 6(12), e29249
• PULESTON, R, MYLES, P, SIEBERT, P and CHILDS, K, 2011. Where is public health leadership in England? Lancet. 378 (9805), 1776-1777
• PULESTON, R, BUGG, G, HOSCHLER, K, KONJE, J, THORNTON, J, STEPHENSON, I, MYLES, P, ENSTONE, J, AUGUSTINE, G, DAVIS, Y, ZAMBON, M, NICHOLSON, K and NGUYEN-VAN-TAM, J, 2010. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy Health Technol Assess. 14(55), 1-82
• PULESTON, R, 2010. Feeding the beast BMJ: (rapid response to: Godlee F. Questions for research (Editor’s choice). 340, c94
• 2010. Final Report to Defra. Investigation of the taxonomy and biology of the Cryptosporidium rabbit genotype.: Contract number WT1226. Contractor: Dr Rachel Chalmers et al (includes Puleston RL). 1-64
• PULESTON, R, Safety data on bevacizumab: (rapid response to: Chakravarthy U. Bevaeizumab for the treatment of neovascular age related macular degeneration BMJ. 340, c2834